Astrazeneca
IMFINZI
Manufacturer:
Astrazeneca
Name:
IMFINZI
Category:
J Code
HCPCS:
J9173
NDC(s):
00310-4500-12, 00310-4611-50,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
IMFINZI is a Cancer drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The J Code: J9173 is aligned to the drug IMFINZI.
Imfinzi works by blocking a protein on the surface of cancer cells called PD-L1. Imfinzi is administered via intravenous infusion over a one-hour time frame. Imfinzi was previously aligned to the temporary HCPCS C9492 before receiving the permanent HCPCS J9173. Patient support for this medication can be found through Astrazeneca Pharmaceuticals AZ & Me prescription savings program here: https://www.azandmeapp.com/prescriptionsavings/. Additionally, patient support for Imfinzi can be found here: https://www.myaccess360.com/imfinzi-durvalumab.html.